Pages

Tuesday, April 9, 2013

Health Care Reform Articles - April 9, 2013

Today's blog is catch-up day, and is therefore a little longer than usual.
-SPC

Where Does It Say the Supreme Court Has the Constitutional Power to Hike Medicine Prices to 5x Their Cost?

The Supreme Court oral arguments on marriage equality deserved all the attention they received — but it’s another case heard this week that will affect even more people over the course of their lifetimes. And it could cost Americans millions in prescription drug bills.
The case falls within a sadly predictable continuum for the Roberts Court, which virtually always sides with the corporate litigant over the government or individual. This time, the arguments in FTC v. Actavis revolve around an insidious tactic common to the nation’s largest drug companies, and known as “pay for delay.” As a result of the likely ruling in this case, drug companies will be able to charge consumers as much as five times the potential cost of their products. And both government regulators and consumers will watch helplessly as pharmaceutical companies bribe generic drug makers to retain their exclusive holds on the lifesaving medicines we all inevitably require.
The first thing to know here is that U.S. pharmaceuticals get a very good deal from the federal government. For every new drug they produce, they get rewarded with long-term patents that grant them exclusive rights to market and sell the product for as much as 20 years – which guarantees them billions in profits and no competitors in the marketplace. Drug companies claim that they must be allowed to profit off of products they nurtured with expensive research and development. In reality, taxpayer-funded research from academia or the National Institutes of Health account for the vast majority of vital drugs brought to market every year, and R&D is a small fraction [2] of the overall drug company budget. What’s more, drug companies routinely use their monopoly power to jack up pharmaceutical prices, which cost far more in the U.S. [3] than anywhere in the world.
Congress tried to deal with this problem as far back as 1984. The Hatch-Waxman Act accelerated the FDA approval process for generic drugs, essentially copies of the brand-name products. Typically, generics sell at a much lower price – in most cases by 80-90 percent, which obviously makes them quite popular. So the introduction of a generic drug basically ends the profitability for the brand-name manufacturer, while delivering big benefits to the consumer. Under Hatch-Waxman, companies can sell generics before the expiration of the exclusive patent by successfully challenging the patents’ validity (and there are often grounds for such a challenge, as drug company lawyers often find every loophole imaginable to extend their patent life or acquire new patents for slightly different versions of the same drug).
http://www.alternet.org/print/drugs/where-does-it-say-supreme-court-has-constitutional-power-hike-medicine-prices-5x-their-cost


Using Medicaid Dollars for Private Insurance



The Obama administration and Republican officials in several states are exploring ways to redirect federal money intended to expand Medicaid, the main public insurance program for the poor, and use it instead to buy private health insurance for Medicaid recipients. The approach could have important benefits for beneficiaries and for the future of health care reform. But the idea also carries big risks. Federal officials will need to enforce strict conditions before agreeing to any redirection of Medicaid dollars that were originally intended to enlarge the Medicaid rolls.
The Supreme Court ruled last year that the states could decide whether they want to expand their Medicaid programs to cover more of the uninsured; they can’t be required to do so, as the health reform law intended.
The law provides hugely attractive financial incentives for states to add more people. The federal government will pay 100 percent of the cost of caring for newly eligible enrollees for the first three years, tapering to 90 percent in later years. Even so, some state officials, mostly Republicans, are proposing that the very generous federal financing for expansion be used instead to pay the premiums of poor people on new electronic health care exchanges, created by the reform law, where people can shop for subsidized private insurance.
Private insurance obtained on the exchanges could help poor beneficiaries in several ways. They would be less vulnerable to disruptions every time their incomes fluctuated above or below the boundary line that determines whether they are poor enough to qualify for Medicaid, where they would see one array of doctors, or slightly better off and eligible for subsidized insurance on the exchanges, where they might see a completely different group of doctors. Providers would be paid the same amount whether treating a Medicaid recipient or a privately insured patient, potentially creating a wider network of doctors for Medicaid patients. And some poor residents of states resistant to expansion, who would otherwise be frozen out by a glitch in the reform law, could gain coverage through the exchanges.
But the main benefit would be political in that it could engage Republicans in the whole health reform effort, make it easier to carry out the law and reduce the appetite among Congressional Republicans to gut the law.
There are at least two big caveats. The switch would be likely to increase costs for the federal government, and ultimately state governments, because private insurance is almost always more costly than Medicaid. That could force a cutback in the number of people covered because the money won’t go as far. There is also a risk that poor people will end up with fewer benefits and higher cost-sharing on the exchanges despite regulations that should prohibit that.

Hospitals take on building projects despite MaineCare debt

Posted March 31, 2013, at 6:44 a.m.
As drivers pass through Augusta on Interstate 95, Maine’s newest hospital comes into view just off Exit 113. Four stories of brick and gleaming glass now stand in what was once a grassy field, a $322 million project just months away from opening to patients as the Alfond Center for Health.
Just a few miles away, lawmakers continue a heated debate about how to repay Maine’s hospitals $484 million in overdue Medicaid bills dating to 2009. Hospitals have stressed the debt’s consequences — from layoffs to frozen wages to eliminated services — in pressing legislators to make good on the state’s long-standing IOU.
Yet a brand-new hospital still managed to be built in Augusta. Two of the state’s other large hospitals in Bangor and Portland also have embarked on multimillion-dollar construction projects.
All three hospitals have financed their projects without assuming that the state will repay the debt, as Gov. Paul LePage has vowed to do. Each pulled together enough capital and loans to get the projects off the ground, even as they’re waiting for Maine to pay up on tens of millions of Medicaid dollars.
Hospital executives say the projects represent needed upgrades that will better serve patients. Others question whether hospitals are being held accountable for all the growth, including employers frustrated by the higher costs that often follow.

Moving forward without MaineCare money

LePage wants the state to pay its $186 million share of the Medicaid debt, which would trigger a federal match of $298 million.
The debt piled up as hospitals served patients covered by MaineCare, Maine’s version of the Medicaid health insurance program for the poor, without being fully reimbursed by the state, which splits the bill for the program with the federal government.
While LePage and lawmakers remain at odds over how to repay the MaineCare debt, there’s no debate that the state has run up a hefty tab. Hospitals also are giving away more charity care and racking up additional losses from patients who can’t pay their medical bills.
Still, hospitals have managed to stay open and in many cases expand. Maine hospitals employed about 36,000 full- and part-time workers in 2011, a jump of about 2,400 from 2007, according to a January report by the American Hospital Association.
As the state fell short on its MaineCare payments, hospitals shifted the burden of those unpaid medical bills to people with private health insurance — namely, Maine’s employers, said Wayne Gregersen, who oversees employee health benefits at The Jackson Laboratory in Bar Harbor.
That “hidden tax” on employers has kept Maine’s hospitals out of debt, he said.
“When they get those overdue hospital payments, they’re just going to be floating in money. … As far as I’m concerned, they’re getting paid twice,” Gregersen said.


Posted March 30, 2013, at 1:22 p.m.
Gov. Paul LePage stirred up Twitter Wednesday afternoon when he pledged to give up his pension if Democrats in the Legislature had the hospital bill on his desk by Saturday. It’s unclear how serious LePage was about this pledge, considering he ended the tweet with “Ya mon,” a reference to his current trip to Jamaica, but it’s certainly not the first time the governor has made waves with a surprising or controversial comment. Here’s a selection of some of LePage’s ‘greatest hits’ from his time in the Blaine House and during his campaign for governor.
• March 1, 2013: “I don’t care if it’s my bills. I’ll veto my own bills.” — LePage promises to veto any bill that comes across his desk until the Legislature passes his plan to repay $484 million owed to the state’s hospitals.
• January 2013:  You guys, you’re idiots and you’re just as bad if not worse than those other guys.” — LePage comparing independent lawmakers to Democrats during a meeting with three independent legislators on alternate approaches to balancing the state budget.
• Nov. 9, 2012: “ If you want a good education in Maine, and I get criticized by my opponents because I’m hard on education, but if you want a good education, go to an academy. If you want a good education go to private schools. If you can’t afford it, tough luck. You can go to the public school.” — LePage discusses school choice during an “Eggs ‘n Issues” talk at York County Community College.
• July 12, 2012:  The Holocaust was a horrific crime against humanity and, frankly, I would never want to see that repeated. Maybe the IRS is not quite as bad — yet.” — LePage compares the IRS to the Gestapo during an interview with Seven Days, an alternative weekly newspaper in Burlington, Vt. He later apologized for his remarks.
• March 31, 2012: “That [criticism] is coming from a little spoiled brat from Portland. He’s very fortunate that his granddad was born ahead of him.” — LePage on Sen. Justin Alfond, D-Portland, when asked about Democratic calls for an investigation of the Department of Health and Human Services.
• March 15, 2012: “The press. Reading newspapers in the state of Maine is like paying somebody to tell you lies.” — LePage to a student who asked him what he didn’t like about his job during his appearance as keynote speaker at a Career Conversations event at Waterville Junior High School.
• March 25, 2011:  I’d laugh at them, the idiots. That’s what I would do. Come on! Get over yourselves!” — LePage when asked what he would do if people formed a human chain to block the removal of the mural from the state Department of Labor.
• February 2011: “The only thing that I’ve heard is if you take a plastic bottle and put it in the microwave and you heat it up, it gives off a chemical similar to estrogen. So the worst case is some women may have little beards.” — LePage saying he has yet to see enough science to support a ban on BPA, a common additive to plastics that some research suggests may interfere with hormone levels and could cause long-term problems.
• Jan. 14, 2011:  Tell them to kiss my butt.” — LePage to reporters in response to suggestions from NAACP members and others that his decision not to attend ceremonies honoring Rev. Martin Luther King Jr. was part of a negative pattern.
• September 2010: “As your governor, you’re going to be seeing a lot of me on the front page, saying ‘Governor LePage tells Obama to go to hell.’” — LePage telling a crowd of fishermen that, if elected, they could expect to see him stand up to the Obama administration.

A.D.H.D. Seen in 11% of U.S. Children as Diagnoses Rise



Nearly one in five high school age boys in the United States and 11 percent of school-age children over all have received a medical diagnosis of attention deficit hyperactivity disorder, according to new data from the federal Centers for Disease Control and Prevention.
These rates reflect a marked rise over the last decade and could fuel growing concern among many doctors that the A.D.H.D. diagnosis and its medication are overused in American children.
The figures showed that an estimated 6.4 million children ages 4 through 17 had received an A.D.H.D. diagnosis at some point in their lives, a 16 percent increase since 2007 and a 41 percent rise in the past decade. About two-thirds of those with a current diagnosis receive prescriptions for stimulants like Ritalin or Adderall, which can drastically improve the lives of those with A.D.H.D. but can also lead to addiction, anxiety and occasionally psychosis.
“Those are astronomical numbers. I’m floored,” said Dr. William Graf, a pediatric neurologist in New Haven and a professor at the Yale School of Medicine. He added, “Mild symptoms are being diagnosed so readily, which goes well beyond the disorder and beyond the zone of ambiguity to pure enhancement of children who are otherwise healthy.”
And even more teenagers are likely to be prescribed medication in the near future because the American Psychiatric Association plans to change the definition of A.D.H.D. to allow more people to receive the diagnosis and treatment. A.D.H.D. is described by most experts as resulting from abnormal chemical levels in the brain that impair a person’s impulse control and attention skills.
While some doctors and patient advocates have welcomed rising diagnosis rates as evidence that the disorder is being better recognized and accepted, others said the new rates suggest that millions of children may be taking medication merely to calm behavior or to do better in school. Pills that are shared with or sold to classmates — diversion long tolerated in college settings and gaining traction in high-achieving high schools — are particularly dangerous, doctors say, because of their health risks when abused.
The findings were part of a broader C.D.C. study of children’s health issues, taken from February 2011 to June 2012. The agency interviewed more than 76,000 parents nationwide by both cellphone and landline and is currently compiling its reports. The New York Times obtained the raw data from the agency and compiled the results.

Small Firms’ Offer of Plan Choices Under Health Law Delayed



WASHINGTON — Unable to meet tight deadlines in the new health care law, the Obama administration is delaying parts of a program intended to provide affordablehealth insurance to small businesses and their employees — a major selling point for the health care legislation.
The law calls for a new insurance marketplace specifically for small businesses, starting next year. But in most states, employers will not be able to get what Congress intended: the option to provide workers with a choice of health plans. They will instead be limited to a single plan.
The choice option, already available to many big businesses, was supposed to become available to small employers in January. But administration officials said they would delay it until 2015 in the 33 states where the federal government will be running insurance markets known as exchanges. And they will delay the requirement for other states as well.
The promise of affordable health insurance for small businesses was portrayed as a major advantage of the new health care law, mentioned often by White House officials and Democratic leaders in Congress as they fought opponents of the legislation.
Supporters of the law said they were disappointed by the turn of events.
The delay will “prolong and exacerbate health care costs that are crippling 29 million small businesses,” said Senator Mary L. Landrieu, Democrat of Louisiana and the chairwoman of the Senate Committee on Small Business and Entrepreneurship.
In the weeks leading up to the passage of the health care legislation in 2010, Ms. Landrieu provided crucial support for the measure, after securing changes to help small businesses.
The administration cited “operational challenges” as a reason for the delay. As a result, it said, most small employers buying insurance through an exchange will offer a single health plan to their workers next year.

Low-Cost Drugs in Poor Nations Get a Lift in Indian Court



NEW DELHI — People in developing countries worldwide will continue to have access to low-cost copycat versions of drugs for diseases like H.I.V. and cancer, at least for a while.
Production of the generic drugs in India, the world’s biggest provider of cheap medicines, was ensured on Monday in a ruling by the Indian Supreme Court.
The debate over global drug pricing is one of the most contentious issues between developed countries and the developing world. While poorer nations maintain they have a moral obligation to make cheaper, generic drugs available to their populations — by limiting patents in some cases — the brand name pharmaceutical companies contend the profits they reap are essential to their ability to develop and manufacture innovative medicines.
Specifically, the decision allows Indian makers of generic drugs to continue making copycat versions of the drug Gleevec, which is made by Novartis. It is spelled Glivec in Europe and elsewhere. The drug provides such effective treatment for some forms of leukemia that the Food and Drug Administration approved the medicine in the United States in 2001 in record time. The ruling will also help India maintain its role as the world’s most important provider of inexpensive medicines, which is critical in the global fight against deadly diseases. Gleevec, for example, can cost as much as $70,000 a year, while Indian generic versions cost about $2,500 a year.
The ruling comes at a challenging time for the pharmaceutical industry, which is increasingly looking to emerging markets to compensate for lackluster drug sales in the United States and Europe. At the same time, it is facing other challenges to its patent protections in countries like Argentina, the Philippines, Thailand and Brazil.
“I think other countries will now be looking at India and saying, ‘Well, hold on a minute — India stuck to its guns,’ ” said Tahir Amin, a director of the Initiative for Medicines, Access and Knowledge, a group based in New York that works on patent cases to foster access to drugs.
In trade agreements — including one being negotiated between the United States and countries in the Pacific Rim — the drug industry has lobbied for stricter patent restrictions that would more closely resemble protections in the United States.

A Prescription for Frustration



Time spent in hospitals brings out the inner Chekhov in some doctors, the inner Che in others. Then there are the occasional hybrids, the storytellers who secretly plot revolution and the revolutionaries who wind up telling fairy tales.
One might argue that Dr. Leana Wen and Dr. Joshua Kosowsky belong to the latter group. At least, their impressive “When Doctors Don’t Listen” is a manifesto motivated by very active imaginations, not that this necessarily diminishes the book’s importance.
The authors, both emergency room physicians at Brigham and Women’s Hospital in Boston, do a fine job of sorting through most of the serious problems in American medicine today, including the costs, overtesting, overprescribing, overlitigation and general depersonalization. All are caused at least in part, they argue, by the increasing use of algorithms in medical care.
Algorithms are flow charts, created by groups ranging from individual hospitals to large professional organizations, dictating what tests doctors should order and what medications they should prescribe in hundreds of different situations. Deployed throughout medicine, the algorithms are perhaps used most frequently in emergency rooms, where any single word a patient utters may set off a long cascade of programmed activity.
Thus, people who say “fever” and “cough” are likely to find themselves being evaluated and treated according to a “pneumonia” algorithm; a mention of chest pain will land them on a “heart attack” algorithm. And such is the power of these decision trees that even if you are a circus employee and Jumbo the elephant has just stepped on your chest, the chances are that once you say “chest pain” you will wind up on that heart attack pathway, just in case.
There are good reasons behind this kind of rote decision making. The great river of suffering and complaint that churns through E.R. doors demands some kind of quickly imposed external order. Algorithms help standardize medical care and ensure that no life-threatening conditions are accidentally overlooked.
But doctors who use too many algorithms practice what is commonly disparaged as “cookbook” medicine — you combine ingredients like blood tests and CT scans, and out pops a diagnosis. (Or, more often, the absence of one: “Well, at least we know it wasn’t a heart attack!”) Even dummies can do it.
Group pushes for vote on single-payer health care in Colorado
DenverPost.com
Even as state officials scramble to put in place major health reforms for 2014, a new proposal to guarantee medical care as a human right and create a single-payer system for all citizens is moving toward a Colorado vote.
Health Care for All Colorado and a current board member of the budding state health insurance exchange are pushing a citizen initiative to scrap the private insurance system.
The effort is separate from Sen. Irene Aguilar's bill proposing a statewide referendum on a "cooperative" that also would be a single-payer system, whose passage with a two-thirds majority is seen as having a slim chance.
The citizens group wants to press on, bypassing requirements for a legislative super-majority to directly test state sentiment on revolutionary fixes for gaps they say were left by 2010's national health reform.
"Access to health care is a human right, it's not something that should be bought and sold as a commodity," said Donna Smith, executive director of Health Care for All Colorado.
Skeptics and critics abound, even within the same progressive movement. Aguilar wonders why the organizers are competing with her effort, while conservatives deride universal coverage as an even worse idea than current big-government health reforms.
"Wait, I thought Obamacare fixed the health care system!" said Linda Gorman, health care analyst for the libertarian Independence Institute. The European and Canadian single-payer systems "are unbelievably expensive for what you get," Gorman said.
"They eliminate treatment and physician choice, make everyone wait for care, degrade the infrastructure needed to diagnose and cure disease, and result in widespread denial of care to those who are seriously ill," she said.

U.S. to boost rather than cut payments to health insurers

By Published: April 1

The Obama administration reversed itself Monday, scrapping plans to cut by 2.2 percent the rates paid to health insurers that take part in the Medicare Advantage program.
The insurance industry and more than 100 members of Congress had objected to the cut in the per capita growth rate, which was proposed in February. They argued that the administration was using faulty methodology. The insurers mounted a vigorous campaign, using television ads and phone banks, to persuade lawmakers to oppose the reduction.
On Monday, the Centers for Medicare and Medicaid Services (CMS) announced that it was changing its method of calculating reimbursement rates. Instead of cutting payments for Medicare Advantage plans, it will increase them by 3.3 percent.
“The policies announced today further the agency’s goal of improving payment accuracy in all our programs, while at the same time ensuring program stability and preserving beneficiary choice,” Jonathan Blum, the CMS’s acting principal deputy administrator, said in a statement.
Twenty-seven percent of Medicare beneficiaries — about 13 million people — get their benefits through the private health insurers that make up the Medicare Advantage program, according to the nonpartisan Kaiser Family Foundation.
The cut would have been one of several directed at the Medicare Advantage program. The plans still face payment reductions and a new tax under the 2010 health-care law.
“Today, CMS rightly acted to reverse course and implement a responsible rate that will preserve choices and ensure continued access to top-notch quality and affordable care for beneficiaries enrolled in the popular Medicare Advantage program,” Sen. Orrin G. Hatch (R-Utah) said in a statement.


A little-known loophole in President Obama’s landmark legislation enables health insurers to extend existing policies for nearly all of 2014.
A new fight is brewing over health insurance companies letting millions of Americans renew their current coverage for another year — and thereby avoid changes under the federal healthcare law.
That may offer a short-term benefit for certain consumers and shield some of those individual policyholders from potentially steep rate increases. But critics say this maneuver could undermine government efforts to remake the insurance market next year and keep premiums affordable overall.
At issue is a little-known loophole in President Obama’s landmark legislation that enables health insurers to extend existing policies for nearly all of 2014. This runs contrary to the widespread belief that all health insurance must immediately comply with new federal rules starting Jan. 1, when most provisions of the law take effect.
“Insurers are onto this, and the big question is how many will try to game the system,” said Timothy Stoltzfus Jost, a law professor and health policy expert at Washington and Lee University.
Some of the nation’s biggest health insurers are looking to take advantage of this delay, and Arkansas officials are encouraging companies to do this by resetting customers’ renewal dates for the end of December. There’s also concern that some insurers and agents could rush to sell more individual policies before year-end so they could be extended in 2014.
Some policy experts are expressing concern about this practice for fear that insurers will focus on renewing younger and healthier policyholders and hold them out of the broader insurance pool next year. Their absence could leave a sicker and older population in new government insurance exchanges, driving up medical costs and premiums there.
“This could undermine the Affordable Care Act, and it opens the door for exacerbating potential rate shock in the exchanges,” said Christine Monahan, a senior analyst at Georgetown University’s Health Policy Institute. “The health insurers can cherry-pick some healthy people and it raises prices for everyone else.”

Dementia Care Cost Is Projected to Double by 2040



The most rigorous study to date of how much it costs to care for Americans with dementia found that the financial burden is at least as high as that of heart disease orcancer, and is probably higher. And both the costs and the number of people with dementia will more than double within 30 years, skyrocketing at a rate that rarely occurs with a chronic disease.
The research, led by an economist at the RAND Corporation, financed by the federal government, and published Wednesday in The New England Journal of Medicine, provides the most reliable basis yet for measuring the scale of the problem. Until now, the most-cited estimates of the condition’s cost and prevalence came from an advocacy group, the Alzheimer’s Association.
Although some figures from the new research are lower than the association’s projections, they are nonetheless staggering and carry new gravity because they come from an academic research effort. Behind the numbers is a sense that the country, facing the aging of the baby boom generation, is unprepared for the coming surge in the cost and cases of dementia.
“It’s going to swamp the system,” said Dr. Ronald C. Petersen, who is chairman of the advisory panel to the federal government’s recently created NationalAlzheimer’s Plan and was not involved in the RAND study.
If anything, Dr. Petersen said of the study’s numbers, “they’re being somewhat conservative.” Dr. Petersen, the director of the Alzheimer’s Disease Research Center at the Mayo Clinic, is part of another team collecting data on dementia costs.
The RAND results show that nearly 15 percent of people aged 71 or older, about 3.8 million people, have dementia. By 2040, the authors said, that number will balloon to 9.1 million people.
“I don’t know of any other disease predicting such a huge increase,” said Dr. Richard J. Hodes, director of the National Institute on Aging, which financed the study. “And as we have the baby boomer group maturing, there are going to be more older people with fewer children to be informal caregivers for them, which is going to intensify the problem even more.”
The study found that direct health care expenses for dementia, including nursing home care, were $109 billion in 2010. For heart disease, those costs totaled $102 billion; for cancer, $77 billion.
The study also quantified the value of the sizable amount of informal care for dementia, usually provided by family members at home. That number ranged from $50 billion to $106 billion, depending on whether economists valued it by the income a family member was giving up or by what a family would have paid for a professional caregiver.

Over 7,000 March to Demand Return of Stolen Health Benefits

By: Kay Tillow Thursday April 4, 2013 9:43 am
 16 arrested in Charleston, WV
Charleston,West Virginia. April 1, 2013.  They boarded buses and cars before dawn, some the night before, coming from the coalfields of Illinois,Pennsylvania,Kentucky,Virginia,Ohio,Indiana, and all acrossWest Virginia.  By10:00 AM over 7,000 had packed into the giant Charleston Civic Center to voice their support for the 23,000 miners and their families who face the loss of their lifetime health benefits in a bankruptcy scam.

In a series of mergers and deals, Peabody Energy and Arch Coal transferred their contractual health benefit obligations to Patriot Coal.  InSt. Louis,Missouri, in March, 2013, Patriot Coal filed in bankruptcy court seeking to terminate the United Mine Workers (UMWA) contract and set up instead a Voluntary Employee Beneficiary Association (VEBA) for the retirees and families. 

Patriot seeks to put only a pittance into the VEBA, vastly underfunding it.  UMWA President Cecil E. Roberts has said this plan would “put thousands of retired coal miners, their dependents or their widows on the path to financial ruin, worsening health conditions or even death.”

The UMWA pioneered in healthcare benefits and pensions when they battled coal operators and the American Medical Association to establish the UMWA Health & Welfare Fund.  John L. Lewis and the union defied accusations of socialized medicine to set up miners’ clinics and built the miners’ hospitals that serve today as the backbone of health care in Appalachia.  The UMWA won early retirement with family coverage for miners who retired before they were 65.  These achievements of the miners’ struggles are under attack by Patriot, Peabody, and Arch.  Most unions, following the lead of the UMWA, have negotiated early retirement with employers picking up the cost of health care until Medicare kicks in.  The attack on UMWA retirees is a snapshot of what employers have in store for union negotiated early retirement plans.
Last chance
If ACA fails, single payer is next
First Published Mar 30 2013 01:01 am • Last Updated Mar 30 2013 01:01 am
The Patient Protection and Affordable Care Act should be seen as what it is: One last opportunity for the private health insurance market to prove that it can offer a service that covers the millions of Americans who were previously left out, at a cost that we — as individuals, employers and taxpayers — can afford.
If that is a goal beyond the grasp of the existing system, then it needs to be finally swept aside in favor of something that will meet those needs.
The most valid critique of the law, better known as Obamacare, is that it does not do enough to reduce, or even retard, increases in the cost of health care across the board. That, in furtherance of its humanitarian goal of catching up to every other industrialized nation by providing near-universal health care, it does too much to increase the cost of that coverage to individuals, employers and taxpayers.
This has been illustrated locally, by the Granite School District’s decision to duck an expected $14 million jump in costs by reducing the hours of hundreds of part-time workers. That way, the district, and its taxpayers, can avoid the ACA mandate that employees who work 30 or more hours a week have to be included in an employer’s health care plan.
And it has been illustrated nationally, by a study that estimates health care insurance claims that are paid may jump by as much as 32 percent per capita as millions more Americans enter that system. Of course, a law that requires health insurance outfits to put actually insuring the health of their customers ahead of their own profits is going to increase the amount of money those companies spend on actual care.
These cost projections, if the ACA works as intended, should be mitigated by other provisions of that act. Health insurance companies should, for example, be limited in how much of the increased cost they can pass along to customers by the provision that at least 80 percent of what an insurance provider spends must be for care, not overhead and profit.
Other factors that could help include increasing access to preventive care now and avoiding more expensive emergency or chronic care later, or moving low-wage workers off their employers’ plans and onto subsidized plans or Medicaid.

3 big providers exploring health alliance


1 comment:

  1. Have a nice post and share with my medical staff friend.Thanks for good day!

    muscle pain relief in Taiwan

    ReplyDelete